“Does stem cell therapy work?” is one of the most common questions patients ask when they begin looking into regenerative medicine. It is also one of the hardest to answer in a simple way. The reason is not that the field is meaningless or vague, but that the question itself is broader than it seems. People are often not really asking whether stem cells can do anything. They are asking whether this kind of therapy can make a meaningful difference in their situation, after other treatments have failed, plateaued, or simply not gone far enough.

That distinction matters. In medicine, there are different types of stem cell therapy. Some, that are clearly established for specific indications, and others, that belong to a more exploratory, evolving space. In most cases, patients are referring to the latter.

What they usually encounter, however, is a confusing mix of hype, skepticism, broad promises, and vague terminology. One website presents stem cell therapy as if it can fix almost anything. Another dismisses it as unproven in general. Neither is particularly helpful to someone trying to make a careful decision.

When someone asks whether stem cell therapy works, they are usually asking one of several more specific questions, depending on their condition. They may be wondering whether it can reduce pain, improve function, shorten recovery time, or help them avoid the need for surgery. In some cases, they are asking whether it can reverse a disease process. In others, they are simply asking whether anything can still shift after years of disappointing treatments.

That is why expectations are so important. If a patient expects a complete reset, many real outcomes will look disappointing even when something meaningful has changed, because most stem cell therapies do not directly resolve the underlying condition.

A patient’s experience illustrates this better than a general explanation. It does not prove a mechanism, and it does not replace clinical trials, but it can show what the question looks like in real life.

Part of the confusion around the expected benefits of stem cell therapy comes from the fact that it is not a single, well-defined treatment. It is an umbrella term that covers very different medical approaches. In established medicine, stem cell transplants have a clear and important role. Bone marrow transplant and blood stem cell transplants, for example, are standard parts of treatment in diseases such as leukemia and other blood-related cancers. These procedures may be used after chemotherapy to help restore the production of healthy blood cells.

That is very different from how stem cell therapy is discussed in regenerative medicine. In this context, the goal is usually not to rebuild an entire blood system, but to influence biological processes involved in inflammation, healing, tissue regeneration, and recovery. These approaches may involve adult stem cells, bone marrow–derived cells, signaling molecules, or other cell therapy methods depending on the clinic and the indication.

There are also major biological distinctions between embryonic stem cells, pluripotent stem cells, adult stem cells, and other cells that play a role in repair or regeneration. Embryonic stem cells, derived from embryos, are capable of becoming many different cell types. Pluripotent stem cells have a similarly broad developmental potential. Adult stem cells are more limited, but are highly relevant in many real medical settings because they participate in maintenance and repair within the body. Researchers continue to study how these different cell types behave, how they influence tissues, and what role they may eventually play in future treatments.

For patients, however, the essential point is simpler: not every therapy marketed under the name “stem cell therapy” is the same, and not every indication has the same level of evidence behind it.

It is important not to collapse all stem cell use into one category. There are areas where stem cell treatment is well established, evidence-based, and part of mainstream medicine. Bone marrow transplant and blood stem cell transplants are obvious examples. In conditions like leukemia, these treatments can be lifesaving. They are used in highly controlled medical settings, often alongside chemotherapy, and supported by extensive clinical trials.

In these situations, the idea of transplanted cells is not speculative. It is part of a well-understood therapeutic framework. Graft biology, blood stem cells, red blood cells, and the restoration of a functioning blood-forming system are all central to these treatments. When people hear the words “stem cell therapy,” this is part of what they are hearing, whether they realize it or not.

But that established oncology context should not be confused with regenerative medicine as a whole. The fact that stem cell transplants are clearly effective in one setting does not automatically mean that stem cell injections or other cell therapy approaches will have the same level of effectiveness in arthritis, knee pain, joint pain, chronic pain, or neurological disease. These are different biological questions, involving different tissues, different disease mechanisms, and different forms of treatment.

In regenerative medicine, the aim is usually not to replace an entire system, but to support the healing process or influence a biological environment that is no longer functioning well. That may involve inflammation, tissue signaling, degeneration, recovery after injury, or impaired communication between cells and other tissues.

This is where many patients with chronic medical conditions begin paying attention. Someone dealing with arthritis, joint health issues, knee pain, chronic pain, degenerative disease, or slow recovery after procedures may begin to wonder whether conventional treatment has reached its limit. If medications, physical therapy, injections, and other procedures only provide partial relief, the attraction of something that might do more than maintain the status quo becomes understandable.

Still, this is the point at which caution is needed. There is a difference between a scientifically plausible therapy and a proven one. Researchers may identify mechanisms suggesting that certain cells or signaling-based approaches could support healing, reduce inflammation, or encourage tissue regeneration. That does not mean that every clinic offering such treatments has strong evidence for every condition listed on its website.

Patients are right to be wary of clinics that blur this distinction. In a field as commercially charged as stem cell therapy, sober judgment matters.

One of our patients, Robert, had been living with a chronic pain condition (CRPS) for more than 14 years.

The symptoms began in his lower left leg and quickly developed into severe, persistent pain.

Without ongoing pain management, his pain remained in the range of 8 to 9 out of 10. Even with regular treatment, it rarely dropped below a 5.

He describes the sensation as a constant burning pain, at times like being stung by “1000 bees simultaneously.” In the early years, the severity led him to consider amputation as a form of relief — something he later understood would not have improved the situation.

At ANOVA CRPS is not an indication we previously had any experience in treating. But the same mechanisms through which stem cell therapies theoretically help in conditions such as ALS, MS, SCI etc., often extend to other conditions such as this one. This is often driven by the lack of effective options in conventional medicine, particularly in rare conditions.

After treatment, there was no resolution of the condition. Pain remained present and daily life was still affected.

However, specific changes occurred. Robert was able to tie his shoe again for the first time in over 14 years. The pain associated with this movement decreased from approximately 7 to around 4. In addition, pain triggered by light contact, such as bedsheets, occurred less frequently. Touch sensitivity remained, but was not consistently overwhelming in the same way as before.

This type of outcome does not represent a cure. It reflects a partial functional improvement and a change in symptom intensity.

In regenerative medicine, this is a more typical pattern. Stem cell–based therapies are not designed to directly reverse complex diseases, but to interact with underlying biological processes such as inflammation and cellular signalling.

As a result, potential effects often refer to:

• reduction in pain

• improved function

• increased tolerance to stimuli

• slower disease progression

This applies across different indications, including chronic pain conditions, spinal cord injury (SCI), and neurodegenerative diseases.

A major misconception is that regenerative medicine is always trying to “grow a new body part” or directly replace damaged tissue with new specialized cells. In some contexts, that idea is relevant. In many others, it is not. Often the goal is more indirect. Therapies may aim to influence signaling, improve the tissue environment, modulate inflammation, or support the conditions under which recovery becomes more possible.

That matters because it changes how outcomes should be interpreted. If the goal is to influence a healing process rather than directly transplant a finished replacement structure, then results may appear as shifts in pain, function, resilience, recovery time, or tolerance rather than complete reversal of disease. A therapy may affect other cells, specific cells, or interactions between different cell types without producing a simple before-and-after transformation.

This is part of why the field attracts both genuine scientific interest and exaggerated claims. The biology is promising enough to justify ongoing investigation, but complex enough that it can easily be oversimplified. Terms like “master cells,” “human stem cells,” and “different cell types” may sound compelling, but they do not by themselves answer the practical question a patient is asking: what is this likely to mean for me?

Expectations in this field tend to fail in two opposite directions. Some patients arrive hoping for full recovery, complete relief, and a return to normality. Others arrive assuming that if the treatment does not change everything, it has failed. Both views are too rigid.

The reality is that many outcomes sit in a middle category. A patient may not become symptom-free, but may notice more stability, less pain, improved function, or a different recovery pattern. They may need fewer supportive treatments, tolerate daily activities better, or feel that the condition has become less dominant in their life. None of that is the same as cure, but none of it is nothing.

This is where Robert’s case is helpful. He did not describe a miracle. He described a shift. The ability to tie his shoe again after years of limitation did not erase the condition, but it changed something concrete. That kind of outcome is easy to miss if the only categories available are “worked” and “didn’t work.”

A more realistic framework is to think in terms of no change, subtle change, meaningful functional change, and in some cases more substantial improvement. That is not as satisfying as a dramatic claim, but often the best outcome that can be hoped for with the current state of stem cell therapy.

Not every disease is equally suitable for the same type of treatment. Not every patient brings the same biological context. The condition itself matters, but so do its duration, severity, tissue environment, inflammatory state, prior treatments, and the individual’s overall health. Recovery is shaped by more than one variable, which is why identical procedures can lead to different outcomes in different patients.

Someone with arthritis may be asking a different question from someone with a neurodegenerative disease. Someone with knee pain may be evaluating the potential benefits of stem cell injections mainly in terms of mobility or delay of surgery. Someone dealing with chronic pain may care more about relief, function, and daily tolerability.

This is also why generic claims about stem cell therapy should be treated carefully. The fact that researchers are studying brain cells, heart muscle cells, blood cells, and other specialized cells does not mean that all these lines of research translate equally into available or effective treatments. There is real science here, but there is also a great deal of variation in how that science is interpreted and used.

Patients should not feel guilty for being skeptical. In fact, a degree of skepticism is healthy. A serious clinic should be able to tolerate difficult questions about effectiveness, evidence, procedures, recovery time, and expected outcomes. It should also be able to distinguish between established treatments, experimental approaches, and pure speculation.

There are clinics that present stem cell therapy as if it were an established treatment option applicable to almost any disease. There are others that rely heavily on patient stories while avoiding discussion of limitations. That is one reason many patients become wary of clinics before they even make contact.

A more trustworthy approach is to acknowledge that regenerative medicine is a mixed field. Some treatments are well established. Some are promising but still developing. Some may offer benefits in certain situations without changing the disease entirely. And some may not help at all.

The most honest answer is that sometimes it does, but not always in the way people imagine. It does not reliably cure every condition. It does not eliminate disease as a category. It does not produce the same recovery in every patient. But it may, in some situations, influence inflammation, support healing, improve function, or create a change that matters to the person living with the condition.

Robert’s experience is one example of why that middle ground matters. The return of one movement after 14 years did not mean his condition had been solved. It meant that a shift had occurred where very little had changed for a long time. For some patients, that is not enough. For others, it is exactly the kind of change that makes the treatment worth considering.

The real question is rarely whether stem cell therapy works in general. It is whether, in a specific case, there is a realistic basis for expecting any meaningful change.

Patients considering stem cell therapy should not approach it as a guaranteed answer, but neither should they assume that only dramatic outcomes count. A serious expectation is often narrower and more practical. Could pain become less dominant? Could function improve? Could recovery shift? Could some aspect of the condition become more manageable than it has been?

Those questions are not less ambitious because they are more realistic. In chronic medical conditions, small changes are often not small at all. Someone who sleeps better, moves more freely, needs fewer supportive procedures, or regains tolerance for a previously impossible activity may experience that as a major improvement, even if the disease remains.

What makes a patient perspective valuable is not that it settles the science. It doesn’t. A patient story cannot replace clinical trials, nor should it be used as if it does. But in this case, Robert's story illustrates the kind of change patients may realistically expect in certain cases.

Stem cell therapy is not for everyone. It is new, experimental and expensive. But for conditions, where all other options have been exhausted, or there are no effective treatments to begin with, stem cell therapy can often make a big difference for patients.

If you are looking into stem cell therapy and want to find out what this kind of treatment might mean in your own situation, you can reach out to our team for further information.